Departments of Pathology and Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC.
Obstet Gynecol. 2017 Sep;130(3):633-635. doi: 10.1097/AOG.0000000000002190.
Rh immunoprophylaxis for Rh-negative women requires an understanding of terminology used for Rh blood typing laboratory reports. The pathophysiology of Rh hemolytic disease of the fetus and newborn was elucidated by studies in rhesus monkeys. Subsequent studies revealed that the human blood group antigen responsible for Rh hemolytic disease of the newborn (D antigen) is related to, but different from, the rhesus monkey antigen. Weak expression of the D antigen on red cells, originally termed D, is currently reported by laboratories as a "serologic weak D phenotype," which can be further defined by RHD genotyping to be either a weak D type or a partial D phenotype. Weak D types 1, 2, or 3 are molecularly defined RHD weak D types, which have an adequate number of intact D antigens to be managed safely as Rh-positive. Partial D phenotypes result from mutations causing loss of one or more D epitopes. Most persons with a partial D phenotype have sufficient D antigen to type as Rh-positive. Some women with a partial D phenotype are detected as serologic weak D phenotypes by routine Rh typing. Whether they type as Rh-positive or serologic weak D phenotype, after being exposed to Rh-positive red cells by transfusion or pregnancy, women with partial D phenotype can form anti-D antibodies and, if they do, are at risk for hemolytic disease of the fetus and newborn. A pregnant woman with a laboratory report of a serologic weak D phenotype should be further tested for her RHD genotype to resolve whether her case should be managed as Rh-positive or Rh-negative. For more than five decades, the practice of Rh immunoprophylaxis has remained unchanged in terms of the dose of Rh immune globulin and timing of injections. In contrast, advances in the science of Rh blood typing have resulted in a continuously evolving terminology, obliging obstetricians to update their vocabulary to guide their practice. The following review and glossary provide guidance for current Rh terminology and the rationale for changes.
Rh 免疫预防需要了解 Rh 血型实验室报告中使用的术语。恒河猴的研究阐明了 Rh 溶血病胎儿和新生儿的病理生理学。随后的研究表明,导致新生儿 Rh 溶血病的人类血型抗原(D 抗原)与恒河猴抗原有关,但不同。红细胞上 D 抗原的弱表达,最初称为 D,目前实验室报告为“血清学弱 D 表型”,可通过 RHD 基因分型进一步定义为弱 D 型或部分 D 表型。弱 D 型 1、2 或 3 是分子定义的 RHD 弱 D 型,其具有足够数量的完整 D 抗原,可安全管理为 Rh 阳性。部分 D 表型是由于突变导致一个或多个 D 表位丢失引起的。大多数部分 D 表型的个体具有足够的 D 抗原,可定型为 Rh 阳性。一些部分 D 表型的妇女通过常规 Rh 定型被检测为血清学弱 D 表型。无论她们是否定型为 Rh 阳性或血清学弱 D 表型,在通过输血或妊娠暴露于 Rh 阳性红细胞后,部分 D 表型的妇女可形成抗-D 抗体,如果形成,她们有患胎儿和新生儿溶血病的风险。实验室报告为血清学弱 D 表型的孕妇应进一步进行 RHD 基因型检测,以确定其病例应作为 Rh 阳性还是 Rh 阴性进行管理。五十多年来,Rh 免疫预防的实践在 Rh 免疫球蛋白的剂量和注射时间方面保持不变。相比之下,Rh 血型鉴定科学的进步导致了术语的不断演变,迫使产科医生更新词汇以指导实践。以下综述和词汇表为当前 Rh 术语提供指导,并为术语变化提供了依据。